ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Mechanism of METTL14 and m6A modification of lncRNA MALAT1 in the proliferation of oral squamous cell carcinoma cells

Li, Jinli; Momen-Heravi, Fatemeh*; Wu, Xun*; He, Kaili南方医科大学
Oral Diseases2023-7DOI: 10.1111/odi.14220
8被引8阅读
引用收藏
分享

摘要

Objectives Methyltransferase-like 14 (METTL14) plays an epigenetic role in various cancer through N6-methyladenosine (m6A) modification. This study sought to analyze the mechanism of METTL14 in oral squamous cell carcinoma (OSCC) cell proliferation. Methods Expression levels of METTL14, lncRNA metastasis associated with lung adenocarcinoma transcript 1 (lncRNA MALAT1), microRNA (miR)-224-5p, and histone lysine demethylase 2A (KDM2A) in OSCC tissues (N = 40), and cell lines (FaDu, SCC-25, CAL-27, and SCC-15) were detected. Cell viability and colony formation capacity were assessed. m6A level, stability, and subcellular localization of lncRNA MALAT1 were determined. Nude mouse xenograft tumor assay was performed to confirm the role of METTL14 in vivo. Results METTL14 and lncRNA MALAT1 were upregulated, and miR-224-5p was downregulated in OSCC tissues and cells. Silencing METTL14 repressed OSCC cell viability and colony formation. Overexpression of MALAT1 and KDM2A or miR-224-5p downregulation reversed the inhibition of silencing METTL14 on OSCC cell proliferation. METTL14 induced m6A modification of MALAT1 to upregulate MALAT1. MALAT1 is comparatively bound to miR-224-5p to promote KDM2A transcription. In vivo, METTL14 promoted tumor growth via regulating MALAT1/miR-224-5p/ KDM2A. Conclusions Overall, our findings verified the therapeutic role of silencing METTL14 in OSCC treatment through the MALAT1/miR-224-5p/KDM2A axis.

学科与关键词

关键词
LncRNA MALAT1m6AMETTL14miR-224-5poral squamous cell carcinoma
相关
加载中…
  • METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1
    Ai, Yilong; Liu, Shiwei; Luo, Hailing; Wu, Siyuan; Wei, Haigang; Tang, Zhe; Li, Xia; Lv, Xiaozhi*; Zou, ChenJournal of Immunology Research, 2021, 2021: 6149558.被引 24
  • Functions, mechanisms, and therapeutic implications of METTL14 in human cancer
    Guan, Qian; Lin, Huiran; Miao, Lei; Guo, Huiqin; Chen, Yongping; Zhuo, Zhenjian*; He, Jing*Journal of Hematology & Oncology, 2022, 15(1): 13.被引 30
  • Roles of m6A modification in oral cancer (Review)
    Liu, Huimin; Wang, Yinyu; Xue, Tianyi; Yang, Zhijing; Kan, Shaoning; Hao, Ming; Gao, Yang; Wang, Dongxu*; Liu, Weiwei*International Journal of Oncology, 2023, 62(1): 5.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
Oral Diseases
发表日期
2023-07
卷期
第 29 卷, 第 5 期
页码
2012-2026
DOI
10.1111/odi.14220
语言
ENGLISH
成果收录
SCIE
资助标注
Southern Medical University Shenzhen Stomatology Hospital; Columbia University Irving Medical Center; Columbia University College of Dental Medicine; Irving Institute for Clinical and Translational Research [UL1 TR001873]; NIH/NIDCR [DE029546-01]; American Association of Cancer Research; Mark Foundation for Cancer Research [20-60-51-MOME]

作者

  • L

    Li, Jinli (第一作者)

  • M

    Momen-Heravi, Fatemeh (通讯)

    new

查看全部 4 位作者收起作者
  • W

    Wu, Xun (通讯)

    southern med univ

  • H

    He, Kaili

    shenzhen childrens hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417